The Effects of Angiotensin-Converting Enzyme Inhibitors on the Clinical and Biochemical Parameters in Diabetic Nephropathy

References

• Knowles H. C. Magnitude of renal failure in diabetic patients. Kidney Int 1974; 6(supp. 1)S-2
   Google Scholar
• Andersen A. R. Prognosis for juvenile diabetics with nephropathy and failing renal function. Aaa Med Scand 1978; 203: 131
   PubMedGoogle Scholar
• Andersen A. R., Christiansen J. S., Andersen J. K., et al. Diabetic nephropathy in type I (insulin-dependent) diabetes: An epidemi-ological study. Diabetologia 1983; 25: 496–501
   PubMed Web of Science ®Google Scholar
• Mauer S. M., Steffes M. W., Ellis E. N., et al. Structural-functional relationship in diabetic nephropathy. J Clin Invest 1984; 74: 1143–1155
   PubMed Web of Science ®Google Scholar
• Miles D. W., Mogensen C. E., Gundersen H. J. Radioimmunoassay for urinary albumin using a single antibody. Scand. J Clin Lab Invest 1970; 26: 5–11
   PubMed Web of Science ®Google Scholar
• Chavers B. M., Simonson J., Michael A. F. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 1984; 25: 576–578
   PubMedGoogle Scholar
• Hostetter T. H., Rennke H. G., Brenner B. M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375–380
   PubMed Web of Science ®Google Scholar
• Mogensen C. E. Urinary albumin excretion in early and long term juvenile diabetes. Scand J Clin Lab Invest 1971; 28: 183–193
   PubMed Web of Science ®Google Scholar
• Parving H. H., Noer I., Deckert T., et al. The effect of metabolic regulation on microvascular permeability to small and large mo-leculas in short-term juvenile diabetes. Diabetologia 1976; 12: 161–166
   PubMedGoogle Scholar
• Viberti G. C., Hill R. D., Jarrett R. J., et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432
   PubMed Web of Science ®Google Scholar
• Friedman E. A. Renal consequences of diabetes. Diabetes Mellitus and Obesity, B N Brodoft, SJ Bleicher. Williams Wilkins, Baltimore 1982; 664–670
   Google Scholar
• Comty C., Shapiro F. End stage diabetic nephropathy. Diabetes Mellitus and Obesity, B N Brodoft, S J Bleicher. Williams and Wilkins, Baltimore 1982; 671–678
   Google Scholar
• Lundbaek K. The kidney in diabetes. Nephrology, J Hamburger, J Crosnier, JP Grunfeld. Wiley-Flammarion, New York 1979; 733–745
   Google Scholar
• Kroustrup J. P., Gundersen HJG, Osterby R. Glomerular size and structure in diabetes. III. Early enlargement of the capillary surface. Diabetologia 1977; 13: 207
   PubMed Web of Science ®Google Scholar
• Seyer H. K. Renal hypertrophy in streptozotocin diabetic rats. Clin Set Mol Med 1976; 51: 551
   Google Scholar
• Stalder G., Schmid R. Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Paediat (Basel) 1959; 193: 129
   PubMedGoogle Scholar
• Ditzel J., Schwartz M. Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 1967; 16: 264
   PubMed Web of Science ®Google Scholar
• Ditzel J., Junker K. Abnormal glomerular filtration rate, renal plasma flow and renal protein excretion in recent and short-term diabetics. Brit Med J 1972; 2: 13
   PubMed Web of Science ®Google Scholar
• Mogensen C. E. Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion rapid hypertonic glucose infusion in normal and diabetic subjects. Scand J Clin Lab Invest 1971; 28: 101
   PubMed Web of Science ®Google Scholar
• Mogensen C. E. Renal function changes in diabetes. DiabetesM 1976; 25(suppl 2)872
   Google Scholar
• Chavers B. M., Bilous R. W., Ellis E. N. Glomerular lesions and urinary albumin excretion in type I diabetes without overt protei-nuria. N Engl J Med 1989; 320: 996–970
   Google Scholar
• Viberti G. C., Hill R. D., Jarret R. J., et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432
   PubMed Web of Science ®Google Scholar
• Parving H. H., Oxsenboll B., Svedsen P. A., et al. Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100: 550–555
   PubMedGoogle Scholar
• Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93
   PubMed Web of Science ®Google Scholar
• Duch'n K L, Steinbacher T. E. Effects of captopril (SO 14,225) on renal function in the dog. Kidney Int 1978; 14: 693
   Google Scholar
• Tobia A., Giardina E. Captopril-induced renal vasodilation in pentobarbital-anesthetized dogs. Fed Proc 1980; 39: 1189
   Google Scholar
• Megss L. G., Hollenberg N. K. Converting enzyme inhibition and the kidney. Hypertension 1980; 39: 1189
   Google Scholar
• Maslowski A. H., Ikram H., Nicholls M. G., et al. Haemodynamic, hormonal and electrolyte response to captopril in resistant heart failure. Lancet 1981; 1: 71–73
   Google Scholar
• Passa P. H., Marre M., Leblanc H. Enalapril, captopril and blood glucose. Lancet 1986; 1: 1147
   Google Scholar
• McCaa R. E., Hall J. E., McCaa C. S. The effects of angiotensin 1-converting enzyme inhibitors on arterial blood pressure and urinary sodium excretion. Role of the renal renin-angiotensin and kallikrein-kinin systems. Circ Res 1978; 43(suppl)32–39
   Google Scholar
• Hornych A., Safar M., Gitelman R., et al (1980) The effect of captopril (C) on plasma and urinary prostaglandins (PG) in essential hypertension. World Conference on Clinical Pharmacology and Therapeutics. August 3–9, 1980. London, Abstract 0410
   Google Scholar
• Crantz F. R., Swartz S. L., Hollenberg N. K., et al. Role of prostaglandins in the hypertensive response to captopril in essential hypertension. Clin Res 1979; 27: 592A
   Google Scholar
• Zimmerman B. G. Actions of angiotensin on adrenergic nerve endings. Fed Proc 1978; 37: 199
   PubMedGoogle Scholar
• Eto M., Watanabe K., Otake Y., et al. Effects of captopril on blood pressure, metabolic control, plasma lipids and proteinuria in elderly hypertensive diabetics. Curr Ther Res 1988; 43: 427–433
   Google Scholar
• Taguma Y., Kitomoto Y., Futaki G., et al. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617–1620
   PubMed Web of Science ®Google Scholar